Switch to:

CRISPR Therapeutics AG Research & Development

: $233.34 Mil (TTM As of Sep. 2020)
View and export this data going back to 2016. Start your Free Trial

This is the expense the company spent on research and development. CRISPR Therapeutics AG's research and development for the three months ended in Sep. 2020 was $71.01 Mil. Its research and development for the trailing twelve months (TTM) ended in Sep. 2020 was $233.34 Mil.


CRISPR Therapeutics AG Research & Development Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Research & Development Premium Member Only 12.57 42.24 69.80 113.77 179.36

CRISPR Therapeutics AG Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.25 48.76 54.19 59.38 71.01

CRISPR Therapeutics AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2020 was 48.761 (Dec. 2019 ) + 54.193 (Mar. 2020 ) + 59.38 (Jun. 2020 ) + 71.008 (Sep. 2020 ) = $233.34 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG  (NAS:CRSP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


CRISPR Therapeutics AG Research & Development Related Terms


CRISPR Therapeutics AG Research & Development Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)